Compare $SNTI vs $VTGN | Chartloom

Compare

$SNTI vs $VTGN

Senti Biosciences Inc · Vistagen Therapeutics Inc

SNTI

Senti Biosciences Inc

VTGN

Vistagen Therapeutics Inc

Compare $SNTI vs $VTGN

Comparing Senti Biosciences Inc and Vistagen Therapeutics Inc

SNTISenti Biosciences Inc

VTGNVistagen Therapeutics Inc

SNTISenti Biosciences Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-71.4%

52W performance

-82.3%

FCF yield

-388.7%

VTGNVistagen Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

278.5%

YTD performance

-65.2%

52W performance

-94.1%

FCF yield

-644.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SNTI

VTGN

Detailed metrics comparison

SNTI

Senti Biosciences Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

SNTI$10M

VTGN$10M

Enterprise Value

SNTI$7M

VTGN$-7M

Price

SNTI$0.31

VTGN$0.24

P/E Ratio

SNTIN/A

VTGNN/A

P/S Ratio

SNTI178.01x

VTGN3.87x

EV/Sales

SNTI133.10x

VTGN-2.92x

EV/EBITDA

SNTI0.00x

VTGN0.00x

P/B Ratio

SNTI3.91x

VTGN0.56x

P/FCF Ratio

SNTIN/A

VTGNN/A

EV/FCF

SNTI-0.19x

VTGN0.12x

PEG Ratio

SNTIN/A

VTGNN/A

Forward P/E (NTM)

SNTIN/A

VTGNN/A

Forward P/S (NTM)

SNTIN/A

VTGNN/A

Revenue (TTM)

SNTI$55K

VTGN$3M

Revenue Growth (YoY)

SNTIN/A

VTGN278.5%

Forward Rev Growth

SNTI-13.8%

VTGN4633.2%

Gross Margin (TTM)

SNTI0.0%

VTGN0.0%

Operating Margin (TTM)

SNTI0.0%

VTGN0.0%

EBITDA Margin (TTM)

SNTI-97030.9%

VTGN-2775.9%

Net Margin (TTM)

SNTI-90116.4%

VTGN-2702.6%

FCF Margin (TTM)

SNTI-69183.6%

VTGN-2493.3%

Net Income (TTM)

SNTI$-50M

VTGN$-68M

FCF (TTM)

SNTI$-38M

VTGN$-62M

EPS (TTM)

SNTI-$1.59

VTGN-$1.57

ROE (TTM)

SNTI-50379.0%

VTGN-15259.0%

ROA (TTM)

SNTI-11312.0%

VTGN-11745.0%

ROIC (TTM)

SNTI-50379.0%

VTGN-15162.0%

Cash

SNTI$6M

VTGN$17M

Debt

SNTI$4M

VTGN$0

Net Cash/Debt

SNTI$2M

VTGN$17M

Current Ratio (TTM)

SNTI0.83x

VTGN3.07x

Quick Ratio (TTM)

SNTI0.47x

VTGN2.84x

Debt/Equity (TTM)

SNTI0.00x

VTGN0.00x

Debt/Assets (TTM)

SNTI0.0%

VTGN0.0%

Interest Coverage (TTM)

SNTIN/A

VTGNN/A

Net Debt/EBITDA (TTM)

SNTI0.00x

VTGN0.00x

Beta

SNTI2.28

VTGN0.49

52W Performance

SNTI-82.3%

VTGN-94.1%

YTD Performance

SNTI-71.4%

VTGN-65.2%

% from 52W High

SNTI-89.1%

VTGN-95.4%

% from 52W Low

SNTI8.4%

VTGN19.2%

Asset Turnover (TTM)

SNTI0.00x

VTGN0.04x

FCF Yield (TTM)

SNTI-388.7%

VTGN-644.0%

Earnings Yield (TTM)

SNTI-506.3%

VTGN-698.0%

Dividend Yield (TTM)

SNTIN/A

VTGNN/A

Rule of 40

SNTI-69,183.6

VTGN-2,214.8

EV/GP/RG

SNTIN/A

VTGNN/A

Ticker research

View SNTI research View VTGN research

Metric	SNTI Senti Biosciences Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$7M	$-7M
Price	$0.31	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	178.01x	3.87x
EV/Sales	133.10x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.91x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.19x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$55K	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	-13.8%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-97030.9%	-2775.9%
Net Margin (TTM)	-90116.4%	-2702.6%
FCF Margin (TTM)	-69183.6%	-2493.3%
Net Income (TTM)	$-50M	$-68M
FCF (TTM)	$-38M	$-62M
EPS (TTM)	-$1.59	-$1.57
ROE (TTM)	-50379.0%	-15259.0%
ROA (TTM)	-11312.0%	-11745.0%
ROIC (TTM)	-50379.0%	-15162.0%
Financial Health
Cash	$6M	$17M
Debt	$4M	$0
Net Cash/Debt	$2M	$17M
Current Ratio (TTM)	0.83x	3.07x
Quick Ratio (TTM)	0.47x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.49
52W Performance	-82.3%	-94.1%
YTD Performance	-71.4%	-65.2%
% from 52W High	-89.1%	-95.4%
% from 52W Low	8.4%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-388.7%	-644.0%
Earnings Yield (TTM)	-506.3%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-69,183.6	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View SNTI research	View VTGN research

Valuation

P/S Ratio

VTGN

3.87x

SNTI

178.01x

EV/FCF

SNTI

-0.19x

VTGN

0.12x

Growth & revenue

Revenue Growth TTM

VTGN

278.5%

Forward Revenue Growth

VTGN

4633.2%

SNTI

-13.8%

Profitability & performance

Gross Margin

SNTI

0.0%

VTGN

0.0%

ROE

VTGN

-15259.0%

SNTI

-50379.0%

FCF Yield %

SNTI

-388.7%

VTGN

-644.0%

52-Week Performance

SNTI

-82.3%

VTGN

-94.1%

Detailed metrics comparison

SNTI

Senti Biosciences Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

SNTI$10M

VTGN$10M

Enterprise Value

SNTI$7M

VTGN$-7M

Price

SNTI$0.31

VTGN$0.24

P/E Ratio

SNTIN/A

VTGNN/A

P/S Ratio

SNTI178.01x

VTGN3.87x

EV/Sales

SNTI133.10x

VTGN-2.92x

EV/EBITDA

SNTI0.00x

VTGN0.00x

P/B Ratio

SNTI3.91x

VTGN0.56x

P/FCF Ratio

SNTIN/A

VTGNN/A

EV/FCF

SNTI-0.19x

VTGN0.12x

PEG Ratio

SNTIN/A

VTGNN/A

Forward P/E (NTM)

SNTIN/A

VTGNN/A

Forward P/S (NTM)

SNTIN/A

VTGNN/A

Revenue (TTM)

SNTI$55K

VTGN$3M

Revenue Growth (YoY)

SNTIN/A

VTGN278.5%

Forward Rev Growth

SNTI-13.8%

VTGN4633.2%

Gross Margin (TTM)

SNTI0.0%

VTGN0.0%

Operating Margin (TTM)

SNTI0.0%

VTGN0.0%

EBITDA Margin (TTM)

SNTI-97030.9%

VTGN-2775.9%

Net Margin (TTM)

SNTI-90116.4%

VTGN-2702.6%

FCF Margin (TTM)

SNTI-69183.6%

VTGN-2493.3%

Net Income (TTM)

SNTI$-50M

VTGN$-68M

FCF (TTM)

SNTI$-38M

VTGN$-62M

EPS (TTM)

SNTI-$1.59

VTGN-$1.57

ROE (TTM)

SNTI-50379.0%

VTGN-15259.0%

ROA (TTM)

SNTI-11312.0%

VTGN-11745.0%

ROIC (TTM)

SNTI-50379.0%

VTGN-15162.0%

Cash

SNTI$6M

VTGN$17M

Debt

SNTI$4M

VTGN$0

Net Cash/Debt

SNTI$2M

VTGN$17M

Current Ratio (TTM)

SNTI0.83x

VTGN3.07x

Quick Ratio (TTM)

SNTI0.47x

VTGN2.84x

Debt/Equity (TTM)

SNTI0.00x

VTGN0.00x

Debt/Assets (TTM)

SNTI0.0%

VTGN0.0%

Interest Coverage (TTM)

SNTIN/A

VTGNN/A

Net Debt/EBITDA (TTM)

SNTI0.00x

VTGN0.00x

Beta

SNTI2.28

VTGN0.49

52W Performance

SNTI-82.3%

VTGN-94.1%

YTD Performance

SNTI-71.4%

VTGN-65.2%

% from 52W High

SNTI-89.1%

VTGN-95.4%

% from 52W Low

SNTI8.4%

VTGN19.2%

Asset Turnover (TTM)

SNTI0.00x

VTGN0.04x

FCF Yield (TTM)

SNTI-388.7%

VTGN-644.0%

Earnings Yield (TTM)

SNTI-506.3%

VTGN-698.0%

Dividend Yield (TTM)

SNTIN/A

VTGNN/A

Rule of 40

SNTI-69,183.6

VTGN-2,214.8

EV/GP/RG

SNTIN/A

VTGNN/A

Ticker research

View SNTI research View VTGN research

Metric	SNTI Senti Biosciences Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$7M	$-7M
Price	$0.31	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	178.01x	3.87x
EV/Sales	133.10x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.91x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.19x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$55K	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	-13.8%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-97030.9%	-2775.9%
Net Margin (TTM)	-90116.4%	-2702.6%
FCF Margin (TTM)	-69183.6%	-2493.3%
Net Income (TTM)	$-50M	$-68M
FCF (TTM)	$-38M	$-62M
EPS (TTM)	-$1.59	-$1.57
ROE (TTM)	-50379.0%	-15259.0%
ROA (TTM)	-11312.0%	-11745.0%
ROIC (TTM)	-50379.0%	-15162.0%
Financial Health
Cash	$6M	$17M
Debt	$4M	$0
Net Cash/Debt	$2M	$17M
Current Ratio (TTM)	0.83x	3.07x
Quick Ratio (TTM)	0.47x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.49
52W Performance	-82.3%	-94.1%
YTD Performance	-71.4%	-65.2%
% from 52W High	-89.1%	-95.4%
% from 52W Low	8.4%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-388.7%	-644.0%
Earnings Yield (TTM)	-506.3%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-69,183.6	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View SNTI research	View VTGN research